FDA wants patients to use less acetaminophen

Share this article:

The FDA elevated acetaminophen overdose concerns Tuesday, urging HCPs to avoid prescription combination medications with more than 325 mg of the analgesic.

The regulator said that there is not proven benefit to taking more than 325 mg, but that that the very same dose increases the risk of liver injury.

Tuesday's notice comes three years after the FDA asked manufacturers to cap acetaminophen content to 325 mg per tablet or capsule by January 14 of this year.

The pain reliever is one of the most commonly used medications, both as a standalone and as a built-in component of many medications, and concern about how much patients are taking has been rising for some time: Time wrote in 2011 that Tylenol overdoses were the leading cause of liver failure in the US.

A 2009 FDA compilation of acetaminophen use showed 8 million OTC acetaminophen-only products were sold in 2005, 9.7 million acetaminophen-plus OTC products were sold in 2005, and that hydrocodone-acetaminophen prescription drugs were the most dispensed drugs between 1997 and 2005.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters